Navigation Links
Rapid Plasma Reagin (RPR with Reflex to Fluorescent Treponemal Antibody, IgG Confirmation

ProductsRapid Plasma Reagin (RPR with Reflex to Fluorescent Treponemal Antibody, IgG Confirmation
Company ARUP Laboratories
Item Rapid Plasma Reagin (RPR with Reflex to Fluorescent Treponemal Antibody, IgG Confirmation
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. RapidLab 248 Blood Gas Analyzer
2. Rapidlab 800 System
3. Rapidlab 348 Blood Gas Analyzer
4. Rapidpoint 400
5. Rapidlink Critical Care Information Management System
6. IDS Rapid NF Plus
7. IDS Rapid NH
8. IDS Rapid One
9. IDS Rapid SS/u
10. IDS Rapid STR
11. IDS Rapid Yeast Plus
A custom blend for Applied Biosystems by FMC. Designed specifically for the electrophoresis of PCR products.
...rs on the PK7200 Automated Microplate System, the ...latin particle for the detection of cytomegaloviru... assay as compared to EIA measures 99.8% and 99.3%...e carrier provides excellent lot-to-lot consistenc...
The Ortho AutoVue System is an automated immunohematology testing system used for blood typing, antibody screening and compatibility testing using Ortho BioVue System cassettes.
TANGO is designed for medium to large transfusion services, donor centers and reference laboratories performing ABO/Rh testing and antibody screening. It will perform a host of functions including bl
Medicine Products:
(Date:12/2/2008)...s establish special bonds between partners. Oftent...rships, and ultimately, the start of families. , ...o much emotional weight on their relationship. As ...self-worth solely based on the outcomes of their r...erm as relationship-contingent self-esteem (RCSE),...
(Date:12/2/2008)...swire-USNewswire/ -- Today, advocates for teen,da...e coming together at Liz,Claiborne Inc. to launch...n,Dating Abuse. Ann and Chris Burke, educators an...y her abusive ex-boyfriend, are joining efforts wi...s national coalition that will,consist of parents...
(Date:12/2/2008)...wire-USNewswire/ -- Today a group of health profe...fficials and other community leaders from more tha...ayne County to solidify participants, understandin...c successes and challenges play a role in determin...g session of a three-day discussion to consider ho...
(Date:12/2/2008)...es a day linked to atrial fibrillation, study fin...-- A healthy middle-aged woman can have up to two ...normal heartbeat called atrial fibrillation, a new... M. Albert, a professor of medicine at Harvard Med...en,s Health study, looking for a relationship betw...
Breaking Medicine News(10 mins):Health News:Too much commitment may be unhealthy for relationships, UH psychology professor says 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News:Light Drinking Poses No Heart Risk for Women 2
...duce fatty deposits that build up in the arteries ...e to reverse the development of heart disease // s...high doses of a powerful cholesterol-lowering drug...patients, including ten in Scotland. The two-year ...
...said that there would be a significant damage to a...a plan of action against the avian flu. // The IM...that a pandemic would trigger sharp fall in the pr...rism and trade would recede and lead to boycotting...
...land is in for a raise, and slated to go up by 15p...April, 2006. // The cost of a prescription now wil...arly ?430m extra in revenue. The charge for a pre...also be up by 75p - to ?34.65 for a period of four...
...lo have been able to identify two key components i...of oral bone loss in future. Oral bone loss is det...s vital to hold it in place. // Researchers compa... patients and related them with the levels of sali...
Other Medicine News:Health News:Crestor to Prevent Heart Disease 2
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)...1 TargeGen has announced that an o...ulti-center, US-based clinical,trial of TG101348 ...heduled at,the 2008 American Society of Hematolog...ation are as follows:, Title: A..., JAK2-Selective Inhibitor...
(Date:12/1/2008)... is still the best policy , , ROCHESTER, M...y from Mayo Clinic finds the use of the drug thera...patitis, an acute inflammation of the liver caused...of the study are published in the December issue o...g/ ). , , VIDEO ALERT: Additional audio an...
(Date:12/1/2008)...1 Vical Incorporated (Na....0 million milestone payment from Merck & Co.,...se I clinical trial of an investigational plasmid ...s based on Vical,s DNA gene delivery technology an...hTERT). hTERT is the subject of separate license a...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2New Type of Stent Shows Promise 29498 1New Type of Stent Shows Promise 29498 2New Type of Stent Shows Promise 29498 3New Type of Stent Shows Promise 29498 4Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 1Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 2Interferon Reduces Eliminates Viral Infections in Heart Failure Patients 29494 3Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 1Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 2Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 3Type 2 Diabetics Studied in Low Dose Aspirin Trial 29492 4Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 1Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 2Tailored Drug Delivery Reduces Adverse Effects After PCI 29488 3
...s Shows Statistically Significant Changes in,Agita...March 26, 2007 /PRNewswire-FirstCall/ --,Alexza Ph...al,results from its Phase IIa clinical trial of AZ...nts with acute agitation. The 10 mg,dose of AZ-004...hich was a statistically-significant reduction in ...
...RE 2 Findings Suggest Improved Outcomes in Carotid...7 /PRNewswire-FirstCall/ --,Positive 30-day result...nting can be performed with positive results by,ph...n real-world,(non-clinical trial) settings in pati... Interim results from the first 1,500,patients enr...
Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4